How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Radiologic Isotope Identification Devices (RIID) Market
- By Device Type: Handheld RIIDs, Portable RIIDs, Fixed RIIDs, Vehicle-Mounted RIIDs
- By Detector Type: Sodium Iodide (NaI) Detectors, High Purity Germanium (HPGe) Detectors, Cadmium Zinc Telluride (CZT) Detectors, Lanthanum Bromide (LaBr3) Detectors
- By Application: Nuclear Security and Border Control, Environmental Monitoring, Emergency Response and Homeland Security, Industrial Radiography, Medical and Pharmaceutical
- By End User: Government and Defense Agencies, First Responders and Emergency Services, Nuclear Power Plants, Research Laboratories, Customs and Border Protection
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Handheld RIIDs leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 274 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 14 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Radiologic Isotope Identification Devices (RIID) Market report
A complete, evidence-based study - 11 chapters and 115 sections covering market size, segmentation across 4 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Device Type 4
Detector Type 4
Application 5
End User 5
Companies profiled
Thermo Fisher Scientific
Mirion Technologies
FLIR Systems (Teledyne Technologies)
Canberra Industries (Mirion Technologies)
Berthold Technologies
Smiths Detection
ORTEC (AMETEK)
Nuctech Company Limited
Ludlum Measurements Inc.
Saphymo (Mirion Technologies)
Nuclear Measurement Corporation (NMC)
Bicron (a division of Mirion Technologies)
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Mirion Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →FLIR Systems (Teledyne Technologies)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Canberra Industries (Mirion Technologies)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Berthold Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Smiths Detection
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ORTEC (AMETEK)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nuctech Company Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Ludlum Measurements Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Saphymo (Mirion Technologies)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nuclear Measurement Corporation (NMC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bicron (a division of Mirion Technologies)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Rapiscan Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Atomtex
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,253M by 2033 · 9.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Handheld RIIDs64.5
- Portable RIIDs12.0
- Fixed RIIDs11.3
- Vehicle-Mounted RIIDs12.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,515M → $3,337M · 10.4%
Europe$1,056M → $1,976M · 8.2%
Asia Pacific$964.1M → $1,740M · 7.7%
Latin America$596.8M → $1,229M · 9.5%
Middle East and Africa$459.1M → $956.6M · 9.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.102026
9.112027
9.142028
9.152029
9.162030
9.172031
9.192032
9.192033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific15.6
- Mirion Technologies18.4
- FLIR Systems (Teledyne Technologies)6.8
- Canberra Industries (Mirion Technologies)5.4
- Berthold Technologies12.8
- Smiths Detection13.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type14.6%
Detector Type41.3%
Application12.9%
End User31.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.1
- Europe21.4
- Asia Pacific18.8
- Latin America13.3
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 86 | 90 | 93 | 87 | 96 | 76 | 88 |
| Mirion Technologies | 77 | 78 | 91 | 69 | 85 | 76 | 79 |
| FLIR Systems (Teledyne Technologies) | 81 | 70 | 75 | 80 | 84 | 74 | 77 |
| Canberra Industries (Mirion Technologies) | 72 | 57 | 63 | 69 | 75 | 59 | 66 |
| Berthold Technologies | 67 | 74 | 52 | 70 | 75 | 66 | 67 |
| Smiths Detection | 56 | 62 | 59 | 56 | 68 | 48 | 58 |
| ORTEC (AMETEK) | 64 | 42 | 47 | 45 | 48 | 57 | 51 |
| Nuctech Company Limited | 60 | 50 | 56 | 53 | 43 | 36 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Mirion Technologies
- FLIR Systems (Teledyne Technologies)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Mirion Technologies | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| FLIR Systems (Teledyne Technologies) | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Canberra Industries (Mirion Technologies) | ◐ | ◐ | ◐ | ✓ | − | ◐ |
| Berthold Technologies | ◐ | ◐ | ◐ | − | ◐ | − |
| Smiths Detection | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| ORTEC (AMETEK) | − | ◐ | − | ◐ | − | ◐ |
| Nuctech Company Limited | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific88
2Mirion Technologies79
3FLIR Systems (Teledyne Technologies)77
4Berthold Technologies67
5Canberra Industries (Mirion Technologies)66
6Smiths Detection58
7ORTEC (AMETEK)51
8Nuctech Company Limited50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificMirion Technologies
Challenger2
Strong scale, closing on the leaders.
FLIR Systems (Teledyne Technologies)Berthold Technologies
Contender2
Focused players with pockets of strength.
Canberra Industries (Mirion Technologies)Smiths Detection
Niche2
Specialists in a single segment or region.
ORTEC (AMETEK)Nuctech Company Limited
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Radiologic Isotope Identification Devices (RIID) Market — a $628M beachhead inside a $9.45B market.
Beachhead (SOM)$628Mobtainable near-term
Serviceable (SAM)$3.62Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Handheld RIIDs
Best fit — highest urgency & budget in Device Type.
Economic buyer78 fit
Portable RIIDs
Strong fit — clear ROI and a fast path to value.
End user69 fit
Fixed RIIDs
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Detector Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel29%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Radiologic Isotope Identification Devices (RIID) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified21%
Evaluation11%
Closed-won8%
$18.2KCAC
$86KLTV
4.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Radiologic Isotope Identification Devices (RIID) Market is a resilient opportunity — $3.28B by 2033, compounding at 5.7%.
TAM · 2025$2.11Btoday
TAM · 2033$3.28Bforecast
CAGR5.7%2027–2033
Cumulative$23.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.28BTotal addressable market
SAM$1.33BServiceable available market
SOM$249MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.7% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.28BLarge & growingTAM by 2033 at 5.7% CAGR
$1.33BServiceable nowreachable with today’s model
$249MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.56BBear3.7% CAGR
$3.28BBase5.7% CAGR
$4.20BBull7.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Detector Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Radiologic Isotope Identification Devices (RIID) Market — a $4.81B market by 2033. Plan: grow share from 8.3% to 16.8%.
Market size · 2033$4.81Btotal addressable
Market CAGR4.1%2027–2033
Target share16.8%from 8.3% today
Revenue ambition$809Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 16.8% | At risk |
| Revenue | $439M | $809M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 32.8% | 43.1% | At risk |
| Customer retention | 87.5% | 96.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Detector Type capability
A defensible second engine — invest in Detector Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Detector Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $96M capacity & capability investment
- Greenlight bolt-on M&A in Detector Type
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Radiologic Isotope Identification Devices (RIID) Market conversation — a $7.59B market you can size, segment and defend in minutes.
Market size · 2033$7.59Btotal opportunity
Growth3.9%CAGR to 2033
Addressable buyers1,264+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 3 mopayback period
$74K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Thermo Fisher ScientificMirion TechnologiesFLIR Systems (Teledyne Technologies)Canberra Industries (Mirion Technologies)Berthold TechnologiesSmiths DetectionORTEC (AMETEK)Nuctech Company Limited+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Radiologic Isotope Identification Devices (RIID) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Radiologic Isotope Identification Devices (RIID) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Radiological Protection Fibre Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportRadiological Diagnostics Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportRadiological Detector Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportRadioligand Therapy Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportRadioisotope Therapy Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportRadioisotopes in Medicine Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportRadioisotopes in Market
Market size, share, segmentation and regional forecast.
$743M market · 2025 base year
View reportRadioisotope Detectors Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportRadioimmunotherapy Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportRadioimmunoassays Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportRadio Immunoassay Reagents and Devices Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportRadioimmunoassay Analyzer Market
Market size, share, segmentation and regional forecast.
$745M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.